Left Right
Michael C. Barnes, Esq.

Michael C. Barnes, Esq.

Partner

Licensed to practice in the District of Columbia and Virginia

Michael C. Barnes is a partner at DCBA Law & Policy, where he provides strategic counsel to businesses, not-for-profit organizations, and individuals. His practice is focused heavily on public policy, corporate responsibility, and regulatory compliance in the areas of health care and drug safety.

Mr. Barnes is a leading advocate for individual rights and innovative responses to some of the top policy issues in the U.S., including the opioid, heroin, and fentanyl crisis; health care; criminal justice reform; and privacy. He regularly provides legal and political analysis for FOX Business.

Mr. Barnes is chairman of the Center for U.S. Policy, a not-for-profit organization dedicated to enhancing Americans’ health, safety, and opportunity. He has been a member of the advisory board for the National Rx Drug Abuse & Heroin Summit since 2011, the National Sheriffs’ Association’s Drug Enforcement Committee since 2014, and the editorial board for the Journal of Opioid Management since 2015.

Mr. Barnes was a political appointee under President George W. Bush, having served as confidential counsel in the White House Office of National Drug Control Policy. Prior to entering the legal profession, Mr. Barnes worked on political and issue campaigns, and was an editor at a national political news site.

Mr. Barnes obtained his Juris Doctor degree from George Mason University School of Law. He earned a master’s degree in international economic policy from La Universidad de Belgrano in Buenos Aires, Argentina, where he lived and studied as a Rotary Foundation International Ambassadorial Scholar. He received his bachelor’s degree summa cum laude from Flagler College.

Speaking Engagements | Publications

Speaking Engagements (2016-Present)

American Society for Pain Management Nursing (ASPMN) 28th National Conference
September 27, 2018
Bonita Springs, FL
“The Impacts of Law, Regulation, and Enforcement on Pain Care: An Update”
Presenter

PAINWeek 2018 National Conference
September 5-6, 2018
Las Vegas, NV
“Legislation and Litigation: Moving Targets Impacting Patient Care”
Moderator, Presenter
“Trusted Not Busted: Staying Compliant in a Litigious Environment”
Presenter

Congressional Briefing on Warm Handoff
June 28, 2018
Washington, DC
“Modernizing Opioid Addiction Treatment Protocol: Emergency Departments As a Point of Care”
Moderator

West Coast Symposium on Addictive Disorders
June 1-2, 2018
La Quinta, CA
“To Disclose or Not to Disclose: An Update on HIPAA and 42 C.F.R. Part 2”
Keynote Presenter
“Tightening the Reins: An Update on Legislation and Enforcement Affecting Residential Treatment Programs and Sober Homes”
Presenter

Providers’ Clinical Support System
May 16, 2018
Webinar
“Pain Care Legislation and Public Policy”
Presenter

American Academy of Pain Medicine’s 34th Annual Meeting
April 28, 2018
Vancouver, British Columbia
“Legislation and Litigation: Moving Targets Impacting Patient Care”
Presenter

National Rx Drug Abuse & Heroin Summit
April 2-5, 2018
Atlanta, GA
“Neuroscience for the Non-Scientist”
Moderator
“Knowledge and Agility: Pivoting in Response to Federal and State Health Policy Changes”
Presenter, Moderator
“Gender Differences and Substance Abuse: Eliminate Discrimination, Improve Treatment and Save Lives”
Moderator
“Project Warm Hand Off: From Rescue to Treatment”
Moderator

Minnehaha County Criminal Justice Mental Health Summit
March 28, 2018
Sioux Falls, SD
“Leveraging Law To Support Behavioral Health Interventions”
Presenter

The University of Memphis Law Review 2018 Symposium
March 16, 2018
Memphis, TN
“Addressing America’s Addiction and Overdose Crisis: Warm Handoff Policy Recommendations”
Presenter, Panelist

Addiction Executives Industry Summit and Police, Treatment, and Community Collaborative
March 4-6, 2018
Ponte Vedra, FL
“Warm Handoff Policies and Programs: Collaborative Efforts To Intervene and Treat Addiction”
Keynote Presenter
“The Straight and Narrow Bottom Line: Law and Ethics Related to Third-Party Payment”
Presenter

Moments of Change 2017 Conference
October 4, 2017
Palm Beach, FL
“One Step Forward or Two Steps Back? Legislation and Litigation Impacting the Future of Addiction Treatment”
Presenter

American Society for Pain Management Nursing (ASPMN) 27th National Conference
September 14, 2017
Phoenix, AZ
“Have the Political Changes of 2017 Benefited People with Pain? Regardless, We Can”
Presenter

PAINWeek 2017 National Conference
September 6-9, 2017
Las Vegas, NV
“How Policy, Guidelines and The Media Challenge Patient Access to Opioid Management”
Moderator, Presenter
“How Many Lawyers Does It Take To Keep a Practitioner out of Trouble?”
Moderator, Presenter
“Making America Treatment Friendly Again: Federal Policy and Pain”
Presenter

American Society of Plastic Surgeons Advocacy Summit
June 28, 2017
Washington, DC
“Spotting and Spurning the Risks of Black Market and Improperly Compounded Drugs”
Presenter

West Coast Symposium on Addictive Disorders
June 1-4, 2017
La Quinta, CA
“Getting Patients in the Door the Right Way: Law and Ethics of Marketing Practices”
Presenter
“Show Me the Money: Law and Ethics of Billing & Collection Practices”
Presenter

National Rx Drug Abuse & Heroin Summit
April 18-19, 2017
Atlanta, GA
“Four Ds To Success: Leveraging Innovation To Change Behaviors, Prevent Substance Use and Enhance Treatment”
Presenter
“Leveraging Federal and State Parity Laws”
Moderator
“Case Studies in Partnership: County Health Department/University Health System and State Health Department/HIDTA”
Moderator

American Academy of Pain Medicine’s 33rd Annual Meeting
March 16, 2017
Orlando, FL
“How Policy, Guidelines, and the Media Challenge Patient Access to Opioid Pain Management: Shifting the Focus from Politics to Patients”
Roundtable Participant

Providers’ Clinical Support System for Opioid Therapies (PCSS-O)
March 8, 2017
Webinar
“Pain Care & Prescription Drug Abuse: Current Topics, Legislation & Policy”
Presenter
5th Annual Tampa Drug Prevention Summit
February 20, 2017
Tampa, FL
“Reducing Prescription Drug Abuse: Effective Strategies and Recommendations”
Presenter

Addiction Executives Industry Summit
February 1, 2017
Naples, FL
“Navigating the Complexity of Varying Standards: State, Federal, and Insurer”
Presenter

Human Abuse Liability & Abuse-Deterrent Formulations Conference
November 2, 2016
Arlington, VA
“Essential Elements of Legislation to Foster a Transition to Medications with Abuse-Deterrent Properties”
Plenary Presenter

National Association of State Controlled Substances Authorities Annual Conference
October 20, 2016
New Orleans, LA
“Science, Not Stigma, Should Drive Policy: An Update on Medications with Abuse-Deterrent Properties”
Presenter

PAINWeek 2016 National Conference
September 9-10, 2016
Las Vegas, NV
“Trends in Federal and State Policy and Their Impacts on Pain Management”
Faculty
“Managing the Risks of Prescribing Controlled Medications”
Faculty

American Society for Pain Management Nursing (ASPMN) 26th National Conference
September 8, 2016
Louisville, KY
“A Call for Balance in Pain Care & Prescription Drug Abuse Prevention: Legislation & Policy”
Presenter, Panelist

Congressional Roundtable on Opioids (U.S. Rep. Ryan Costello, PA-6)
July 26, 2016
Pottstown, PA
“Compassion, Not Contempt: The Essential Elements of Opioid-Related Policies”
Presenter, Panelist

International Conference on Opioids
June 6, 2016
Boston, MA
“If Not You, Who? A Call for Informed Professionals To Engage in Opioid-Related Policy Making”
Presenter

National Conference of State Legislatures
May 14, 2016
New Orleans, LA
“The Realities of Pain: Treatments, Costs, Challenges, and Solutions”
Faculty
“Innovations in Pain Management”
Faculty

Alliance for the Adoption of Innovations in Medicine
May 13, 2016
Washington, DC
“Closing Legal Loopholes To Improve Health Care”
Moderator

Broward Behavioral Health Conference: Building Healthier Communities
May 10, 2016
Fort Lauderdale, Florida
“Engaging Policy Makers To Advance Compassion and Eliminate Contempt in Behavioral Health Policy”
Presenter

Millennium Health Educational Program
April 14, 2016
Webcast
“Urine Drug Testing in Substance Use Disorder Treatment: A Consensus-Based Ethical Approach”
Presenter

New York State Pain Society
April 1-3, 2016
West Harrison, NY
“Establishing Clinically Rational and Ethically Sound Urine Drug Testing Protocols”
Presenter

National Rx Drug Abuse & Heroin Summit
March 28-31, 2016
Atlanta, GA
“Buprenorphine: Knocking Out Pill Mills and Minimizing Diversion”
Presenter
“Addiction Is a Disease, Not a Choice, and Should Be Treated As Such”
Moderator
“Best Practices in Treating Opioid Addiction in the Criminal Justice Population”
Moderator
“Advances in Treating Chronic Pain and Addiction”
Moderator

Abuse-Deterrent Formulations Summit
March 9-10, 2016
Alexandria, VA
“The Impacts of Federal and State Policy on the Development and Use of Abuse-Deterrent Medications”
Presenter

Addiction Executives Industry Summit
January 31-February 3, 2016
Naples, FL
“Legal, Policy, and Ethical Issues in Addiction Treatment”
Keynote Presenter

The Pain Society of the Carolinas
January 30, 2016
Charleston, SC
“Establishing Clinically Rational & Ethically Sound UDT Protocols”
Presenter

Providers’ Clinical Support System for Opioid Therapies
January 27, 2016
Webinar
“Pain Care and Prescription Drug Abuse: Current Topics, Legislation, and Policy”
Presenter

Publications

Michael C. Barnes & Daniel C. McClughen, Warm Handoffs: The Duty of and Legal Issues Surrounding Emergency Departments in Reducing the Risk of Subsequent Drug Overdoses, U. Mem. L. Rev. (forthcoming).

Michael C. Barnes, et al., Potential Impact of Texas et al v United States on Persons with Substance Use Disorder, ABA Health eSource (Oct. 2018), available at https://www.americanbar.org/.

Michael C. Barnes, Diligence and Documentation: Managing the Risks of Prescribing Controlled Substances, 5 PainWeek J. 52 (2017).

Michael C. Barnes, et al., What’s in a Number? Recommending Practicality in the DATA 2000 Patient Limits, 12 J. Opioid Manag. 243 (2016).

Michael C. Barnes, et al., A Call for Differential Diagnosis of Non-Specific Low Back Pain to Reduce Opioid Abuse, 101 J. of Med. Reg. 39 (2015).

Michael C. Barnes & Stacey L. Worthy, Evaluating Motives: Two Simple Tests to Identify and Avoid Entanglement in Legally Dubious Urine Drug Testing Schemes, 11 J. Opioid Manag. 89 (2015).

Michael C. Barnes, et al., Abuse-Deterrent Formulations: Transitioning the Pharmaceutical Market to Improve Public Health and Safety, 6 Therapeutic Advances in Drug Safety 1 (2015).

Michael C. Barnes & Stacey L. Worthy, Achieving Real Parity: Increasing Access to Treatment for Substance Use Disorders Under the Patient Protection and Affordable Care Act and the Mental Health and Addiction Equity Act, 36 U Ark Little Rock L. Rev. 555 (2015).

Michael C. Barnes & Stacey L. Sklaver, Applying Lessons from the Opioid Abuse Epidemic to Protect Consumers from Gray Market Biologics, 29 Notre Dame J.L. Ethics & Pub. Pol’y 375 (2015).

Michael C. Barnes & Stacey L. Sklaver, Active Verification and Vigilance: A Method To Avoid Civil and Criminal Liability When Prescribing Controlled Substances, 15 DePaul J. Health Care L. 93 (2013).

Michael C. Barnes & Gretchen Arndt, The Best of Both Worlds: Applying Federal Commerce and State Police Powers To Reduce Prescription Drug Abuse. 16 J. Health Care L. & Pol’y 271 (2013).

Michael C. Barnes, et al., A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 1 & Part 2, J. on Global Drug Pol’y & Prac. Vol. 3, Issue 4 (2009).